425 related articles for article (PubMed ID: 29250791)
1. Successful management of severe red blood cell alloimmunization in pregnancy with a combination of therapeutic plasma exchange, intravenous immune globulin, and intrauterine transfusion.
Nwogu LC; Moise KJ; Klein KL; Tint H; Castillo B; Bai Y
Transfusion; 2018 Mar; 58(3):677-684. PubMed ID: 29250791
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic plasma exchange and intravenous immunoglobulin as primary therapy for D alloimmunization in pregnancy precludes the need for intrauterine transfusion.
Bellone M; Boctor FN
Transfusion; 2014 Aug; 54(8):2118-21. PubMed ID: 24673470
[TBL] [Abstract][Full Text] [Related]
3. Successful management of maternal anti-PP1P
Hadjiyannis Y; Jones JM; Chibisov I; Kiss J; Gabert K; Sevcik J; Bakdash S; Binstock A; Kilonsky C; Parviainen K; Kaplan A
J Clin Apher; 2024 Jun; 39(3):e22120. PubMed ID: 38733134
[TBL] [Abstract][Full Text] [Related]
4. Effect of intravenous immunoglobulins to postpone the gestational age of first intrauterine transfusion in very severe red blood cell alloimmunization: A case-control study.
Maisonneuve E; Dugas A; Friszer S; Toly-Ndour C; Cariot L; Dhombres F; Cortey A; Mailloux A; Carbonne B; Jouannic JM
J Gynecol Obstet Hum Reprod; 2021 Sep; 50(7):102119. PubMed ID: 33741541
[TBL] [Abstract][Full Text] [Related]
5. Management and clinical consequences of red blood cell antibodies in pregnancy: A population-based cohort study.
Liu S; Ajne G; Wikman A; Lindqvist C; Reilly M; Tiblad E
Acta Obstet Gynecol Scand; 2021 Dec; 100(12):2216-2225. PubMed ID: 34476807
[TBL] [Abstract][Full Text] [Related]
6. Neonatal outcomes following intrauterine transfusion for hemolytic disease of the fetus and newborn: a twenty-year service review.
Blyth U; Larsson M; Baird A; Waring G; Athiraman N
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):10220-10225. PubMed ID: 36121063
[TBL] [Abstract][Full Text] [Related]
7. High additional maternal red cell alloimmunization after Rhesus- and K-matched intrauterine intravascular transfusions for hemolytic disease of the fetus.
Schonewille H; Klumper FJ; van de Watering LM; Kanhai HH; Brand A
Am J Obstet Gynecol; 2007 Feb; 196(2):143.e1-6. PubMed ID: 17306657
[TBL] [Abstract][Full Text] [Related]
8. Severe Rh alloimmunization and hemolytic disease of the fetus managed with plasmapheresis, intravenous immunoglobulin and intrauterine transfusion: A case report.
Houston BL; Govia R; Abou-Setta AM; Reid GJ; Hadfield M; Menard C; Noyd J; Main S; Zarychanski R
Transfus Apher Sci; 2015 Dec; 53(3):399-402. PubMed ID: 26321100
[TBL] [Abstract][Full Text] [Related]
9. Successful management of severe Kell alloimmunization in pregnancy with intravenous immune globulin.
Patris M; Holoye A; Goldman D; De Coninck C; Colard M
Transfus Apher Sci; 2024 Apr; 63(2):103868. PubMed ID: 38238203
[TBL] [Abstract][Full Text] [Related]
10. High anti-HLA response in women exposed to intrauterine transfusions for severe alloimmune hemolytic disease is associated with mother-child HLA triplet mismatches, high anti-D titer, and new red blood cell antibody formation.
Verduin EP; Schonewille H; Brand A; Haasnoot GW; Claas FH; Lindenburg IT; Lopriore E; Oepkes D; Roelen DL; Doxiadis II
Transfusion; 2013 May; 53(5):939-47. PubMed ID: 22924899
[TBL] [Abstract][Full Text] [Related]
11. High-dose gammaglobulin (IVIG) followed by intrauterine transfusions (IUTs): a new alternative for the treatment of severe fetal hemolytic disease.
Voto LS; Mathet ER; Zapaterio JL; Orti J; Lede RL; Margulies M
J Perinat Med; 1997; 25(1):85-8. PubMed ID: 9085208
[TBL] [Abstract][Full Text] [Related]
12. Red blood cell alloimmunization prevalence and hemolytic disease of the fetus and newborn in Israel: A retrospective study.
Rahimi-Levene N; Chezar J; Yahalom V;
Transfusion; 2020 Nov; 60(11):2684-2690. PubMed ID: 32770778
[TBL] [Abstract][Full Text] [Related]
13. Clinical consequences of the extremely rare anti-PP1Pk isoantibodies in pregnancy: a case series and review of the literature.
Di Ciaccio P; Cutts B; Alahakoon TI; Dennington PM; Soo LA; Curnow J
Vox Sang; 2021 May; 116(5):591-600. PubMed ID: 33326620
[TBL] [Abstract][Full Text] [Related]
14. Successful management of fetal hemolytic disease due to strong anti-Rh17 with plasma exchange and intrauterine transfusion in a woman with the D-- phenotype.
Mimura K; Endo M; Takahashi A; Doi Y; Sakuragi M; Kiyokawa T; Taniguchi H; Kitabatake Y; Handa M; Tomimatsu T; Tomiyama Y; Isaka Y; Kimura T
Int J Hematol; 2020 Jan; 111(1):149-154. PubMed ID: 31538326
[TBL] [Abstract][Full Text] [Related]
15. Personalized treatment with immunoadsorption and intravenous immunoglobulin in a case of severe Rh alloimmunization during pregnancy unresponsive to plasma - exchange.
Colpo A; Tison T; Gervasi MT; Vio C; Vicarioto M; De Silvestro G; Marson P
Transfus Apher Sci; 2017 Jun; 56(3):480-483. PubMed ID: 28648573
[TBL] [Abstract][Full Text] [Related]
16. Hemolytic disease of the fetus and newborn: systematic literature review of the antenatal landscape.
de Winter DP; Kaminski A; Tjoa ML; Oepkes D
BMC Pregnancy Childbirth; 2023 Jan; 23(1):12. PubMed ID: 36611144
[TBL] [Abstract][Full Text] [Related]
17. [Intrauterine blood transfusion: Status report of 4years of practice in France (2011-2014)].
Girault A; Friszer S; Maisonneuve E; Guilbaud L; Cortey A; Jouannic JM
J Gynecol Obstet Hum Reprod; 2017 Feb; 46(2):119-124. PubMed ID: 28403966
[TBL] [Abstract][Full Text] [Related]
18. Combined plasmapheresis and intravenous immune globulin for the treatment of severe maternal red cell alloimmunization.
Ruma MS; Moise KJ; Kim E; Murtha AP; Prutsman WJ; Hassan SS; Lubarsky SL
Am J Obstet Gynecol; 2007 Feb; 196(2):138.e1-6. PubMed ID: 17306655
[TBL] [Abstract][Full Text] [Related]
19. Successful management of severe hemolytic disease of the fetus due to anti-Jsb using intrauterine transfusions with serial maternal blood donations: a case report and a review of the literature.
Al Riyami AZ; Al Salmani M; Al Hashami S; Al Mahrooqi S; Al Hinai S; Al Balushi H; Al Riyami N; Gowri V; Al Dughaishi T; Al Hosni S; Al-Khabori M; Al-Farsi K; Al Huneini M; Alkindi S
Transfusion; 2014 Jan; 54(1):238-43. PubMed ID: 23829228
[TBL] [Abstract][Full Text] [Related]
20. Update on HDFN: new information on long-standing controversies.
Eder AF
Immunohematology; 2006; 22(4):188-95. PubMed ID: 17430078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
